Mpox

Mpox is an exotic infectious disease caused by the Mpox virus. The disease was first identified in laboratory monkeys, thus earning its name, but in its natural state, it seems to infect rodents more than primates. A fever, headache, muscle pains, swollen lymph nodes, and fatigue are the first symptoms in humans. After this, a rash forms with blisters and crusts. Symptoms typically appear 7 to 14 days after exposure. In most cases, symptoms last 2 to 4 weeks. Children, pregnant women, and people with suppressed immune systems are at greater risk of severe cases.

Human Monkeypox – Epidemiology, Clinical Characteristics, Diagnosis, and Prevention

The human monkeypox virus, which belongs to the genus Orthopoxvirus of the family Poxviridae, is a DNA virus.

What is Monkeypox?

Monkeypox Epidemiology

Monkeypox 2003 U.S. Outbreak

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

Vaccination reduces risk of severe COVID-19 in solid organ transplant recipients

Findings from a two-year study of nearly 2,400 solid organ transplant recipients, conducted by the Johns Hopkins Transplant Research Center (TRC) in collaboration with the New York University Center for Surgical and Applied Transplant Research, indicate spikes of post-vaccination SARS-CoV-2 viral infections (commonly known as COVID-19 breakthrough cases) remain common, yet hospitalization rates have dramatically dropped following the first wave of the virus' omicron subvariant.

18 Aug 2023

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

The history of using human challenge trials in developing vaccines.

15 Aug 2023

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

The UK Health Security Agency (UKHSA) has today unveiled its world-leading Vaccine Development and Evaluation Centre (VDEC), which is building on its pandemic legacy and helping develop life-saving new vaccines for the UK and worldwide.

7 Aug 2023

UKHSA unveils new strategy to prepare for and respond to health threats

The new strategy sets out UKHSA's vision and goals for the next 3 years to prepare for and respond to health threats and build the capabilities and technologies to protect the country in the future.

25 Jul 2023

Study reports the first local case of mpox caused by imported case in the Chinese mainland

Monkeypox (mpox) is a zoonotic disease caused by the mpox virus (MPXV) that has been primarily limited to Central and West African nations since its discovery.

18 Jul 2023

INTEGRA pipetting solutions accelerate crucial viral genomics research

The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies.

From INTEGRA Biosciences 14 Jul 2023

Government seeks views on proposed changes to the Health Protection Notification Regulations 2010

The Health Protection Notification Regulations 2010 (HPNR) help us respond promptly to suspected cases of infectious disease that could have an impact on public health.

13 Jul 2023

Wastewater monitoring can be an effective tool for global disease surveillance

Wastewater monitoring could act as an early warning system to help countries better prepare for future pandemics, according to a new study.

6 Jul 2023

UCLA-led team receives $925,000 CDC grant for four surveillance projects tracking mpox outbreaks

A UCLA-led team has received $925,000 as part of a new grant from the Centers for Disease Control and Prevention (CDC) to conduct four surveillance projects tracking outbreaks of mpox--formerly known as monkeypox—across the U.S.

3 Jul 2023

Deep learning models could be crucial in battling the monkeypox virus

Researchers developed a machine-learning-based detection tool to detect mpox.

14 Jun 2023

University Hospital Centre for Emerging Viral Diseases named as a WHO collaborating center for epidemic and pandemic diseases

The World Health Organization (WHO), the University of Geneva (UNIGE) and Geneva University Hospitals (HUG), yesterday formalized the designation of the University Hospital Centre for Emerging Viral Diseases as a WHO collaborating center for epidemic and pandemic diseases.

8 Jun 2023

Cutting free flu jabs for 50-64-year-olds and mpox vaccines could lead to future strains on the NHS, says expert

...

5 Jun 2023

Wastewater data unveils underreported Mpox cases in Texas

A recent study characterizes the analytical sensitivity of three assays used to detect MPXV in wastewater samples.

31 May 2023

Mpox incidence across rural and urban areas in the US

Researchers explored the differences in rural and urban mpox incidence in the United States (US).

31 May 2023

CDC reports on its Mpox response

Research paper provides an overview of the U.S. monkeypox outbreak, highlighting the rapid response, vaccination efforts, and racial disparities in cases. Ongoing surveillance, vaccination, and communication are emphasized as crucial for future prevention.

24 May 2023

JYNNEOS vaccine shows strong effectiveness against Mpox in New York outbreak

In the recent Morbidity and Mortality Weekly Report (MMWR) published by the Centers for Disease Control and Prevention (CDC), researchers reported on JYNNEOS vaccine effectiveness (VE) against Mpox infections among New York (NY) residents in 2022.

23 May 2023

Real-world assessment of JYNNEOS vaccine effectiveness during the 2022 mpox outbreak in the US

A recent study published in Morbidity and Mortality Weekly Report estimated the efficacy of the JYNNEOS vaccine against mpox.

22 May 2023

Wastewater surveillance reveals hidden scale of mpox rpidemic, challenging official figures

Research highlights the potential of wastewater-based epidemiology as a complementary tool to clinical monitoring for assessing the magnitude of a mpox epidemic. Findings suggest that the presence of mpox DNA in wastewater does not directly correspond to the number of hospitalizations, indicating the underestimation of the epidemic's scale and unidentified cases.

19 May 2023

Understanding the adverse events profile of MVA-BN vaccine for Mpox

Researchers evaluated adverse events following the Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccination for mpox.

10 May 2023

A multisectoral, global, and interdisciplinary approach is needed for better pandemic preparedness

Researchers reviewed existing data on pandemics and described the steps needed to prevent the emergence.

4 May 2023

Mpox

Overview

What is Monkeypox?

Monkeypox Epidemiology

Monkeypox 2003 U.S. Outbreak

Feature Articles

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

Vaccination reduces risk of severe COVID-19 in solid organ transplant recipients

Human challenge trials: A game-changer in vaccine development? Examining their role in shaping the pandemic response

UKHSA unveils world-leading Vaccine Development and Evaluation Centre

UKHSA unveils new strategy to prepare for and respond to health threats

Study reports the first local case of mpox caused by imported case in the Chinese mainland

INTEGRA pipetting solutions accelerate crucial viral genomics research

Government seeks views on proposed changes to the Health Protection Notification Regulations 2010

Wastewater monitoring can be an effective tool for global disease surveillance

UCLA-led team receives $925,000 CDC grant for four surveillance projects tracking mpox outbreaks

Deep learning models could be crucial in battling the monkeypox virus

University Hospital Centre for Emerging Viral Diseases named as a WHO collaborating center for epidemic and pandemic diseases

Cutting free flu jabs for 50-64-year-olds and mpox vaccines could lead to future strains on the NHS, says expert

Wastewater data unveils underreported Mpox cases in Texas

Mpox incidence across rural and urban areas in the US

CDC reports on its Mpox response

JYNNEOS vaccine shows strong effectiveness against Mpox in New York outbreak

Real-world assessment of JYNNEOS vaccine effectiveness during the 2022 mpox outbreak in the US

Wastewater surveillance reveals hidden scale of mpox rpidemic, challenging official figures

Understanding the adverse events profile of MVA-BN vaccine for Mpox

A multisectoral, global, and interdisciplinary approach is needed for better pandemic preparedness

Ensuring colony counts remain precise and verifiable using a completely automated colony counting system

Pharmatech: The Art of AI-Driven Drug Design with Exscientia

Realizing the Potential of Vendor Engagement with ELRIG's Vendor Strategy Work Group Lead

Mpox

Overview

Feature Articles

Monkeypox; What is It and How Do We Treat It?

Latest Mpox News and Research

Ensuring colony counts remain precise and verifiable using a completely automated colony counting system

Pharmatech: The Art of AI-Driven Drug Design with Exscientia

Realizing the Potential of Vendor Engagement with ELRIG's Vendor Strategy Work Group Lead

Newsletters you may be interested in